loading
전일 마감가:
$21.44
열려 있는:
$21.45
하루 거래량:
342.09K
Relative Volume:
0.34
시가총액:
$1.40B
수익:
$9.98M
순이익/손실:
$-154.08M
주가수익비율:
-8.1725
EPS:
-2.58
순현금흐름:
$-159.66M
1주 성능:
-4.05%
1개월 성능:
+0.52%
6개월 성능:
-6.14%
1년 성능:
-34.22%
1일 변동 폭
Value
$20.73
$21.66
1주일 범위
Value
$20.65
$22.60
52주 변동 폭
Value
$14.40
$47.00

Celldex Therapeutics Inc Stock (CLDX) Company Profile

Name
명칭
Celldex Therapeutics Inc
Name
전화
908-200-7500
Name
주소
53 FRONTAGE ROAD, HAMPTON
Name
직원
186
Name
트위터
@search?q=celldex
Name
다음 수익 날짜
2024-11-04
Name
최신 SEC 제출 서류
Name
CLDX's Discussions on Twitter

CLDX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CLDX
Celldex Therapeutics Inc
21.08 1.47B 9.98M -154.08M -159.66M -2.58
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
385.97 96.11B 11.42B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.30 60.40B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
430.84 54.91B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
672.75 41.30B 3.05B 1.28B -614.78M 19.58
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.34 33.25B 3.81B -644.79M -669.77M -6.24

Celldex Therapeutics Inc Stock (CLDX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-28 개시 Canaccord Genuity Buy
2025-03-20 개시 Morgan Stanley Overweight
2025-02-13 개시 UBS Buy
2024-10-07 개시 Citigroup Buy
2024-09-30 개시 Goldman Neutral
2024-09-27 다운그레이드 Wolfe Research Outperform → Peer Perform
2024-06-18 개시 Stifel Buy
2024-06-11 개시 Wolfe Research Outperform
2023-12-20 개시 TD Cowen Outperform
2023-11-10 업그레이드 Wells Fargo Underweight → Equal Weight
2023-08-22 개시 Wells Fargo Underweight
2021-09-17 개시 Jefferies Buy
2021-09-10 개시 SVB Leerink Outperform
2021-07-22 개시 Guggenheim Buy
2020-02-21 개시 Cantor Fitzgerald Overweight
2017-08-01 재개 H.C. Wainwright Buy
2016-11-07 개시 Aegis Capital Buy
2016-03-08 다운그레이드 Jefferies Buy → Hold
2016-03-07 다운그레이드 Guggenheim Buy → Neutral
2016-03-07 다운그레이드 Leerink Partners Outperform → Mkt Perform
2016-03-07 다운그레이드 Wedbush Outperform → Neutral
2016-03-01 개시 H.C. Wainwright Buy
2015-08-11 재확인 Brean Capital Buy
2015-08-11 재확인 Oppenheimer Outperform
2015-08-11 재확인 ROTH Capital Buy
2015-06-02 재확인 WBB Securities Strong Buy
2014-11-17 재확인 ROTH Capital Buy
2014-03-04 재확인 Oppenheimer Outperform
2013-07-08 재확인 Cantor Fitzgerald Buy
2013-03-08 재확인 Cantor Fitzgerald Buy
2013-02-26 재확인 Oppenheimer Outperform
2013-01-10 재확인 Cantor Fitzgerald Buy
2012-10-02 재확인 Oppenheimer Outperform
2012-09-14 재확인 Cantor Fitzgerald Buy
모두보기

Celldex Therapeutics Inc 주식(CLDX)의 최신 뉴스

pulisher
Aug 06, 2025

Is Celldex Therapeutics Inc. trending in predictive chart modelsEarnings Report Summary with Market Impact - Newser

Aug 06, 2025
pulisher
Aug 05, 2025

How Celldex Therapeutics Inc. stock performs during market volatilityBreakout Momentum Picks With Protection Outlined - metal.it

Aug 05, 2025
pulisher
Aug 04, 2025

Celldex Therapeutics Inc. Charts Flash Early Recovery SignalsLong Hold Safe Return Strategy Reviewed - metal.it

Aug 04, 2025
pulisher
Aug 03, 2025

What makes Celldex Therapeutics Inc. stock price move sharplyHigh-yield market plays - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Celldex Therapeutics Inc. generate profit in a changing economyExponential return rates - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is it the right time to buy Celldex Therapeutics Inc. stockDynamic investment growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What analysts say about Celldex Therapeutics Inc. stockOutstanding capital appreciation - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the dividend policy of Celldex Therapeutics Inc. stockUnprecedented profits - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the risk reward ratio of investing in Celldex Therapeutics Inc. stockTake advantage of unprecedented market momentum - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Should I hold or sell Celldex Therapeutics Inc. stock in 2025Capitalize on strategic market trends - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Why is Celldex Therapeutics Inc. stock attracting strong analyst attentionMarket-beating performance - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Celldex Therapeutics Inc. a good long term investmentTrack high-yield stocks before they peak - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are analysts’ price targets for Celldex Therapeutics Inc. in the next 12 monthsUnlock powerful trading signals for profits - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

Does Celldex Therapeutics Inc. stock perform well during market downturnsInvest in stocks with strong fundamentals - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Celldex Therapeutics Inc. Stock Analysis and ForecastCapitalize on emerging market sectors - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Celldex Therapeutics’ Phase 3 Study on Barzolvolimab: A Potential Game-Changer for Chronic Urticaria - The Globe and Mail

Aug 02, 2025
pulisher
Aug 02, 2025

Can trapped investors hope for a rebound in Celldex Therapeutics Inc.AI Trend Detection for Entry Timing - Newser

Aug 02, 2025
pulisher
Aug 02, 2025

Using R and stats models for Celldex Therapeutics Inc. forecastingFree Safe Entry Stock Watch Suggestions - Newser

Aug 02, 2025
pulisher
Aug 02, 2025

Will Celldex Therapeutics Inc. continue its uptrendWatchlist Generator for Smart Money Signals - Newser

Aug 02, 2025
pulisher
Aug 02, 2025

Top chart patterns to watch in Celldex Therapeutics Inc.Weekly Entry Signal Based Forecast Tool - Newser

Aug 02, 2025
pulisher
Aug 01, 2025

Why Celldex Therapeutics Inc. stock attracts strong analyst attentionRisk-Managed Trade Alerts for Consistency - Newser

Aug 01, 2025
pulisher
Aug 01, 2025

Will Celldex Therapeutics Inc. price bounce be sustainableNeural Network Based Equity Prediction System - Newser

Aug 01, 2025
pulisher
Aug 01, 2025

What to expect from Celldex Therapeutics Inc. in the next 30 daysFree Top Gaining Picks With Entry Signals - Newser

Aug 01, 2025
pulisher
Jul 31, 2025

Celldex Therapeutics Inc. Company’s Quarterly Earnings Growth: What the Numbers SayFree High Yield Stock Screening Results - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

KIT Inhibitors Market Growth: Key Trends and Future Projections in the 7MM Upto 2034 | DelveInsight - PR Newswire

Jul 31, 2025
pulisher
Jul 31, 2025

What are Celldex Therapeutics Inc. company’s key revenue driversSmart Portfolio Planner For Beginners - Jammu Links News

Jul 31, 2025
pulisher
Jul 31, 2025

Visual analytics tools that track Celldex Therapeutics Inc. performanceFree Community Entry Consensus Trade Ideas - Newser

Jul 31, 2025
pulisher
Jul 30, 2025

Is Celldex Therapeutics Inc. stock a good hedge against inflationFree Consistent Gain Investment Strategies - Newser

Jul 30, 2025
pulisher
Jul 30, 2025

Published on: 2025-07-30 04:46:21 - Newser

Jul 30, 2025
pulisher
Jul 29, 2025

Will Celldex Therapeutics Inc. Recover After Recent DeclineMulti-Bagger Potential Stock Forecast Tools Released - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Celldex Therapeutics Inc. Attempts Reversal From Key SupportEarly Breakout Entry Point Notifications Sent - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Sectors Driving Future Growth for Celldex Therapeutics Inc. StockTechnical Trade Plan with Entry Checklist - Newser

Jul 29, 2025
pulisher
Jul 28, 2025

Published on: 2025-07-28 23:24:39 - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

How many analysts rate Celldex Therapeutics Inc. as a “Buy”Build a diversified portfolio for sustainable growth - Jammu Links News

Jul 28, 2025
pulisher
Jul 28, 2025

How does Celldex Therapeutics Inc. compare to its industry peersPowerful growth strategies - Jammu Links News

Jul 28, 2025

Celldex Therapeutics Inc (CLDX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$77.30
price down icon 0.43%
$36.80
price down icon 0.82%
$108.59
price down icon 2.21%
$27.91
price down icon 2.14%
$113.33
price up icon 1.83%
biotechnology ONC
$294.82
price down icon 1.17%
자본화:     |  볼륨(24시간):